The Dis-Chem succession is pivotal as founder Ivan Saltzman resigns from formal roles. Learn about the changes happening now.
Dis-Chem succession enters a new phase
Original Article by Ann Crotty | Financial Mail | 27 August 2026
The Dis-Chem succession is pivotal as founder Ivan Saltzman resigns from formal roles. Learn about the changes happening now.
More Posts
Childhood immunisation coverage falls sharply in SA
Childhood immunisation coverage is falling sharply in SA as measles and other diseases spread. See why health officials are concerned.
Read more...
Rasonque pancreatic cancer drug wins FDA approval
Rasonque, a pancreatic cancer treatment from Revolution Medicines, offers a new option for advanced patients. Discover its benefits.
Read more...
Discovery’s headline earnings set to rise
Discovery’s headline earnings are expected to rise by up to 36%, supported by South African and Vitality growth.
Read more...